- Home
- NVOS vs SHPH Comparison
NVOS vs SHPH Comparison
Compare NVOS & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVOS
- SHPH
- Stock Information
- Founded
- NVOS 2000
- SHPH 2012
- Country
- NVOS United States
- SHPH United States
- Employees
- NVOS N/A
- SHPH N/A
- Industry
- NVOS Assisted Living Services
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- NVOS Health Care
- SHPH Health Care
- Exchange
- NVOS Nasdaq
- SHPH Nasdaq
- Market Cap
- NVOS 5.6M
- SHPH 3.3M
- IPO Year
- NVOS 2017
- SHPH 2022
- Fundamental
- Price
- NVOS $0.23
- SHPH $1.41
- Analyst Decision
- NVOS
- SHPH
- Analyst Count
- NVOS 0
- SHPH 0
- Target Price
- NVOS N/A
- SHPH N/A
- AVG Volume (30 Days)
- NVOS 326.8K
- SHPH 43.1K
- Earning Date
- NVOS 12-12-2024
- SHPH 11-12-2024
- Dividend Yield
- NVOS N/A
- SHPH N/A
- EPS Growth
- NVOS N/A
- SHPH N/A
- EPS
- NVOS N/A
- SHPH N/A
- Revenue
- NVOS $13,516,958.00
- SHPH N/A
- Revenue This Year
- NVOS N/A
- SHPH N/A
- Revenue Next Year
- NVOS N/A
- SHPH N/A
- P/E Ratio
- NVOS N/A
- SHPH N/A
- Revenue Growth
- NVOS 1102.98
- SHPH N/A
- 52 Week Low
- NVOS $0.20
- SHPH $1.03
- 52 Week High
- NVOS $3.45
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- NVOS 38.13
- SHPH 49.84
- Support Level
- NVOS $0.20
- SHPH $1.12
- Resistance Level
- NVOS $0.31
- SHPH $1.26
- Average True Range (ATR)
- NVOS 0.03
- SHPH 0.11
- MACD
- NVOS 0.00
- SHPH 0.06
- Stochastic Oscillator
- NVOS 27.18
- SHPH 68.09
About NVOS Novo Integrated Sciences Inc.
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.